BioHealth News Archive
TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility — TCR2 Therapeutics
CAMBRIDGE, Mass., March 29, 2021 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell…
Read More
BioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic | Global Biodefense
BioFactura, Inc. today announced a contract option activation of over $13 million by the Biomedical Advanced Research and Development Authority (BARDA), part of the…
Read More
8 digital health trends emerging from the pandemic – Technical.ly Baltimore
What did we learn during the pandemic, and what should we watch moving forward? Those are two of the key questions that many professional…
Read More
209 PERRY PARKWAY – GAITHERSBURG, MARYLAND, 20877
SPACE FEATURES Existing laboratory suite with closed and open o ices Grade-level loading doors 17' ceiling heights • breakroom with kitchenette 180 free surface…
Read More
What It Takes to Manufacture a Vaccine | NAM
You may not know it, but one company has the capacity to manufacture bulk drug substance for more than a billion doses of COVID-19…
Read More
Leveraging Artificial Intelligence in Human Health | B.S. in Biocomputational Engineering
The University of Maryland hosted a free webinar, Leveraging Artificial Intelligence in Human Health, on Friday, March 19, 2020. This event featured a fireside chat with Dr. Robert…
Read More
Northern Virginia’s bioscience industry grows stronger | WTOP
Exciting things are happening at Innovation Park in Manassas. Researchers are working on global solutions, industry jobs are on the rise, and new facilities…
Read More
Knowing Your Assets with Richard Bendis Talent Talks Ep. 14
Check out this weeks episode of Talent Talks on YouTube and Spotify! This week we sit with Richard Bendis President and CEO of BioHealth…
Read More
5 Questions with Natalie McKinney, Industry Programs Director, Biologics, US Pharmacopeia · BioBuzz
“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little…
Read More
Construction on New Buildings Underway at Port Covington Development
New buildings are now rising out of the ground on the first major phase of construction at the 235-acre, $5.5-billion, multi-decade Port Covington development.…
Read More
CASI Pharmaceuticals Announces Pricing Of $32,500,000 Public Offering Of Common Stock
ROCKVILLE, Md. and BEIJING, March 24, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative…
Read More
NeoImmuneTech Announces Closing of Initial Public Offering – BioHealth Capital Region
ROCKVILLE, Md.–(BUSINESS WIRE)–NeoImmuneTech, Inc. (KOSDAQ: 950220), a clinical-stage T cell-focused biopharmaceutical company, today announced the closing of its initial public offering of 3,133,334 shares…
Read More
Tribute in Light: AstraZeneca Gaithersburg Campus Honors José Baselga
Our AstraZeneca Gaithersburg Campus will be illuminated this week to pay tribute to José Baselga, our beloved Oncology R&D leader and Site Head who…
Read MoreBethesda’s BrainScope launches Concussion Index, eyes big raise – Washington Business Journal
BrainScope received FDA clearance in September 2016 to sell its first product, which it developed with the Department of Defense to assess a range…
Read More
Novavax trials highlight Maryland’s COVID-fighting complex
When Novavax Inc. received $1.6 billion last year from the federal government to speed up testing and production of a coronavirus vaccine, some observers…
Read More